JESSICA HEMOTA: Open Payments
NPI 1275382798 · WINTER GARDEN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$414 in 6 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $210 · 2025 $414
Food & beverage: $414
| Company | Payments | Amount |
|---|---|---|
| Celltrion USA Inc. | 1 | $133 |
| ABBVIE INC. | 1 | $112 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $111 |
| Ardelyx, Inc. | 1 | $20 |
| Boston Scientific Corporation | 1 | $19 |
| Medtronic, Inc. | 1 | $18 |
Products named: VEGZELMA, SKYRIZI, XIFAXAN, IBSRELA, WallFlex Duodenal, NEXPOWDER.
Industry payments across FL — which companies pay providers there.
